1. Home
  2. RVPH vs ORMP Comparison

RVPH vs ORMP Comparison

Compare RVPH & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVPH
  • ORMP
  • Stock Information
  • Founded
  • RVPH 2006
  • ORMP 2002
  • Country
  • RVPH United States
  • ORMP United States
  • Employees
  • RVPH N/A
  • ORMP N/A
  • Industry
  • RVPH Biotechnology: Pharmaceutical Preparations
  • ORMP Biotechnology: Pharmaceutical Preparations
  • Sector
  • RVPH Health Care
  • ORMP Health Care
  • Exchange
  • RVPH Nasdaq
  • ORMP Nasdaq
  • Market Cap
  • RVPH 88.0M
  • ORMP 90.7M
  • IPO Year
  • RVPH N/A
  • ORMP N/A
  • Fundamental
  • Price
  • RVPH $1.84
  • ORMP $2.37
  • Analyst Decision
  • RVPH Strong Buy
  • ORMP Hold
  • Analyst Count
  • RVPH 5
  • ORMP 1
  • Target Price
  • RVPH $11.40
  • ORMP N/A
  • AVG Volume (30 Days)
  • RVPH 1.6M
  • ORMP 493.8K
  • Earning Date
  • RVPH 11-14-2024
  • ORMP 03-05-2025
  • Dividend Yield
  • RVPH N/A
  • ORMP N/A
  • EPS Growth
  • RVPH N/A
  • ORMP N/A
  • EPS
  • RVPH N/A
  • ORMP 0.11
  • Revenue
  • RVPH N/A
  • ORMP N/A
  • Revenue This Year
  • RVPH N/A
  • ORMP N/A
  • Revenue Next Year
  • RVPH N/A
  • ORMP N/A
  • P/E Ratio
  • RVPH N/A
  • ORMP $21.93
  • Revenue Growth
  • RVPH N/A
  • ORMP N/A
  • 52 Week Low
  • RVPH $0.60
  • ORMP $2.00
  • 52 Week High
  • RVPH $4.50
  • ORMP $3.67
  • Technical
  • Relative Strength Index (RSI)
  • RVPH 47.68
  • ORMP 53.03
  • Support Level
  • RVPH $1.66
  • ORMP $2.16
  • Resistance Level
  • RVPH $2.14
  • ORMP $3.09
  • Average True Range (ATR)
  • RVPH 0.15
  • ORMP 0.15
  • MACD
  • RVPH -0.02
  • ORMP 0.03
  • Stochastic Oscillator
  • RVPH 36.73
  • ORMP 25.77

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

About ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

Share on Social Networks: